- “Medical Boards and CEOs: Evidence from COVID-19 in China”, with Dunhong Jin and Fangzhou Lu.
- “The Unintended Consequences of Anti-Corruption Campaigns Against Securities Regulators: Evidence from Private Equity Placements”, with Zai Li and Jiaxin Wang.
- “Standing Up or Standing By: Abnormally Hot Temperature and Corporate Environmental Engagement”, with Jiaxin Wang, Jingyi Zhuang and Kam C. Chan.
- “Can Corporate Social Responsibility Mitigate Negative Public Sentiment? Evidence from Major Violent Crimes in China”, with Zai Li and Zihan Yin.
- “Do CEOs with New Compound Surnames Have Better ESG Performance? Evidence from China”, with Ziyi Zhang and Yuchun He.
- “The Rise of Wealth Management Products in China: Evidence from the Perspective of Corporate Cash Holdings, with Ziyi Zhang, Jiaxin Wang and Guochao Yang.
- “COVID-19 Outbreak and Stock Prices: Evidence from China”, Permanent Working Paper.